Organometallic Half-Sandwich Dichloridoruthenium(II) Complexes with 7-Azaindoles: Synthesis, Characterization and Elucidation of Their Anticancer Inactivity against A2780 Cell Line

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.
Authors

ŠTARHA Pavel HANOUSKOVÁ Lucie TRÁVNÍČEK Zdeněk

Year of publication 2015
Type Article in Periodical
Magazine / Source Plos one
MU Faculty or unit

Central European Institute of Technology

Citation
Web http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0143871
Doi http://dx.doi.org/10.1371/journal.pone.0143871
Field Biochemistry
Keywords CRYSTAL-STRUCTURES; IN-VITRO; NAMI-A; RUTHENIUM; CYTOTOXICITY; LIGANDS; METALS; INTERCALATION; DERIVATIVES; DRUG
Attached files
Description A series of organometallic half-sandwich dichloridoruthenium(II) complexes of the general formula [Ru(eta(6)-p-cym)(naza)Cl-2] (1-8; p-cym = p-cymene; naza = 7-azaindole or its derivatives) was synthesised and fully characterized by elemental analysis, mass spectrometry, and infrared and multinuclear NMR spectroscopy. A single-crystal X-ray structural analysis of [Ru(eta(6)-p-cym)(2Me4Claza)Cl-2] (6) revealed a typical piano-stool geometry with an N7-coordination mode of 2-methyl-4-chloro-7-azaindole (2Me4Claza). The complexes have been found to be inactive against human ovarian cancer cell line A2780 up to the highest applied concentration (IC50 > 50.0 mu M). An inactivity of the complexes is caused by their instability in water-containing solvents connected with a release of the naza N-donor ligand, as proved by the detailed H-1 NMR, mass spectrometry and fluorescence experiments.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.